Literature DB >> 35521560

Retinal Neovascularization in Two Patients with Incontinentia Pigmenti.

Reiva Farah Dwiyana1, Ivan Daniel Banjarnahor1, Inne Arline Diana1, Srie Prihianti Gondokaryono1, Raden Mohamad Rendy Ariezal Effendi1, Vina Feriza1.   

Abstract

Incontinentia pigmenti (IP) is a rare genodermatosis, inherited in an X-linked dominant pattern, making it generally found among women. Among several characteristics of IP are four phases of skin manifestation that tend to follow Blaschko's lines, in addition to abnormalities of the eye, central nervous system (CNS), and teeth. Ocular involvement in IP patients can occur since birth, which can be classified into retinal or non-retinal disorders. Retinal disorders can result in detachment, which is a major ocular threat for IP patients. This article reports two IP cases with overlapped phases of skin disorders in baby girls with ocular manifestations since early life. Clinical signs and additional examination of the skin and eyes are utilized to make the diagnosis. All the features of the histopathological examination supported the diagnosis of IP, and ocular exams revealed abnormalities in the form of retinal neovascularization (RN). Although RN may resolve spontaneously, patients should be monitored for the development of other eye disorders such as visual impairment.
© 2022 Dwiyana et al.

Entities:  

Keywords:  genodermatosis; incontinentia pigmenti; ocular manifestation; retina

Year:  2022        PMID: 35521560      PMCID: PMC9063803          DOI: 10.2147/CCID.S363179

Source DB:  PubMed          Journal:  Clin Cosmet Investig Dermatol        ISSN: 1178-7015


Introduction

Incontinentia pigmenti (IP) or Bloch-Sulzberger,1–3 is a very rare X-linked dominant disorder, with an incidence of 1.2 per 100.000 births.4,5 Ninety-eight percent of cases are found in women.3,6 This disorder mainly occurs following a mutation in the inhibitor of kappa β kinase gamma (IKBKG) gene,1–3 formerly known as nuclear factor-κβ (NF-κβ) essential modulator (NEMO),4,6 located on the Xq28 segment of the X chromosome.1,2,4,7–9 Skin abnormalities are the first and main clinical manifestations found in IP,2 which could appear at birth or immediately after, especially in the first two weeks of life.3,8 The dermatological abnormalities of IP characteristically follows Blaschko’s lines.4,8 There are four phases of skin disorders in IP,2,3 which includes the vesicular phase, verrucose phase, hyperpigmentation phase, and the hypopigmentation/atrophy phase.3,4 Landy and Donnai in 1993 made diagnostic criteria consisting of major (clinical features typical of IP) and minor criteria for IP10 and then in 2014, Minic et al11 modified it by adding IKBKG gene mutations into the diagnostic criteria. Approximately 80% of IP cases present with extracutaneous manifestations,7 including anomalies of the teeth (30–92%), eyes (36–77%), CNS (28–66%), hair (13–35%), and nails (7–40%).7,9 CNS and ocular manifestations can remain undetected until infancy or early childhood, leading to severe functional nervous system abnormalities such as convulsion, mental retardation,3,12 and muscle spasticity,3 as well as visual impairments ranging from mild to severe, even blindness.2,7,13,14 Ocular manifestations in IP patients may occur since birth7 in the form of retinal or non-retinal disorders.10,15 Retinal disorders include neovascularization, fibrosis, and retinal detachment, whereas non-retinal disorders include nystagmus, cataracts, microphthalmia, uveitis, conjunctival pigmentation and hypoplasia of the iris.10,15 The role of the NF-kB protein in protecting capillary endothelial cells from apoptosis can be used to explain the retinal findings. IKBKG gene mutations cause cell death, which leads to microvascular problems such as retinal ischemia and neovascularization.9 Early screening of ocular disorders are important, as neovascularization of the retina can leads to retinal detachment and blindness,13,14 however some cases may resolve spontaneously.3 This case report aims to present two rare cases of IP in baby girl with ocular manifestations in the form of RN.

Case Presentation

Case 1

A two-month-old baby girl presented with a painless and non-itchy erythematous papules and vesicles on abdomen, groins, and both upper limbs (Figure 1A-D), as well as hyperpigmented macules arranged spindle-like in almost all parts of the body except the face, both palms and soles (Figure 1E). From history taking revealed that the skin lesions appeared since birth in the form of erythematous macules and papules, vesicles, pustules, also verrucous plaque on abdomen, back, both arms and legs. There was no family history with the same features. On physical examination, on almost all parts of the body except the scalp, face, palms and soles, there were hyperpigmented macules distributed linearly and swirled along Blaschko’s lines. Erythematous macules and vesicles were found on abdomen, groins, and both upper limbs. Based on these skin lesions, we diagnosed this patient was IP with vesicular phase overlapped with hyperpigmentation phase. Laboratory examination results showed eosinophilia (12%). No abnormalities were found in the EEG, whereas ophthalmological evaluation by the ophthalmologist showed RN on the peripheral side of the right eye (Figure 1F). Histopathological examination with routine hematoxylin eosin stains, did not support IP. There is no specific treatment for skin lesions, apart from moisturizers. No specific interventions was performed for the retinal disorder, but the patient was advised to undergo routine follow-up for further evaluation. On day 116 of evaluation, the skin lesions resolved, leaving hyperpigmented macular lesions, and the RN achieved spontaneous resolution (Figure 1G).
Figure 1

(A and B) Distribution of typical lesions on almost all parts of the body, except the scalp, face, palm and soles in a two- month-old girl with incontinentia pigmenti. (C) Erythematosus papules and (D) vesicles on the trunk ((D) is the enlargement of a red square region in (C)). (E) Hyperpigmented macules distributed linearly and swirled along Blaschko’s lines. (F) Retinal neovascularization on peripheral part of the right eye at 3 months of age. (G) Normal retinal vasculature on the right eye at 6 months of age.

(A and B) Distribution of typical lesions on almost all parts of the body, except the scalp, face, palm and soles in a two- month-old girl with incontinentia pigmenti. (C) Erythematosus papules and (D) vesicles on the trunk ((D) is the enlargement of a red square region in (C)). (E) Hyperpigmented macules distributed linearly and swirled along Blaschko’s lines. (F) Retinal neovascularization on peripheral part of the right eye at 3 months of age. (G) Normal retinal vasculature on the right eye at 6 months of age.

Case 2

A two-month-old baby girl presented with painless and non-itchy erythematous papules as well as hyperpigmented macules and papules in almost all parts of the body except the face, both palms and feet (Figure 2A and B). From history taking revealed that the skin lesions appeared since birth in the form of erythematous papules and vesicles on both arms, which continuously increased in number and spread all over the body. Some of the erythematous papules and vesicles resolved and formed verrucous papules (Figure 2C-E) and also hyperpigmented macules (Figure 2F and G), whereas new lesions kept appearing. There was no family history with the same complaint. On physical examination, on almost all parts of the body except the face, both palms and feet, there were erythematous macules and papules, vesicles, verrucous papules and also hyperpigmented papules, distributed linearly and swirled along Blaschko’s lines. Linear skin lesions in the form of atrophic striae were found on the medial side of the upper right thigh. Laboratory examination results showed eosinophilia (27%). Based on the clinical features, we diagnosed this patient was IP with vesicular phase overlapped with hyperpigmentation and atrophy phases. No abnormalities were found in the EEG, whereas ophthalmological evaluation by the ophthalmologist showed RN on the peripheral side of the left eye. Histopathological examination with routine hematoxylin eosin stains indicated IP features. The patient was given with a moisturizer and 0.1% mometasone furoate cream to be applied on erythematous papules. No specific interventions were performed for the retinal disorder, but the patient was advised to undergo routine follow-up for further evaluation. On day 140 of evaluation, the skin lesions resolved, leaving hyperpigmented macular lesions, and the RN achieved spontaneous resolution. This patient suffered unrealized visual impairment (myopia and astigmatism) about 7 years later, and it might be related to retinal neovascularization in IP.
Figure 2

(A and B) Distribution of the lesions on almost all parts of the body, except the scalp, face, palm and soles, in a two-month-old girl with incontinentia pigmenti. (C) Verrucous papules left knee and (D–E) finger toes. (F–G) Hyperpigmented macules distributed linearly and swirled along Blaschko’s lines in trunks and both legs.

(A and B) Distribution of the lesions on almost all parts of the body, except the scalp, face, palm and soles, in a two-month-old girl with incontinentia pigmenti. (C) Verrucous papules left knee and (D–E) finger toes. (F–G) Hyperpigmented macules distributed linearly and swirled along Blaschko’s lines in trunks and both legs.

Discussion

The extracutaneous manifestations of IP can found in teeth, eyes, hair, nails and CNS.7,15 A total of 30–92% of patients have dental abnormalities (delayed tooth growth, anodontia, hypodontia, and deformities),15 35–70% of patients have eye involvement (strabismus, cataract, RN, optic atrophy, retinal pigment abnormalities),2,14,15 and 13–35% of patients have CNS involvement (seizures, motor and intellectual impairment).4 In addition, 28–66% of abnormalities in the hair (alopecia), 7–40% of nail abnormalities (ranging from mild pitting to onychodystrophy),15 and 11–30% of nipple aplasia can also be found.4,11,15 Typical skin manifestations of IP may help in early diagnosis of other organ involvement.3 Ocular abnormalities in IP patients is generally unilateral,4,17 and if bilateral involvement is observed, one eye tend to have milder manifestations.17 Clinical manifestations found in the eye may vary,14 and is generally classified into two groups, retinal and non-retinal abnormalities.10,13 Retinal abnormalities are caused by occlusive blood vessel conditions or ischemia, which is compensated by blood vessel proliferation.4,9,15 The impairment usually appears at birth or up to one year old,10 in the form of retinal blood vessel disorders, retinal fibrosis, or retinal detachment.10,15 Meanwhile, non-retinal disorders usually occur before the age of two.10 The most common non-retinal manifestations include strabismus (18–33%) and optic nerve atrophy (4%), whereas nystagmus, cataract, microphthalmia, uveitis, conjunctival pigmentation and hypoplasia of the iris are rarely found.10,15 Minic et al11 reported that retinal blood vessel disorders and retinal detachment are the most common ocular manifestations among IP patients. Untreated eye disorders may lead to retinal detachment and eventual blindness,16 whereas neovascularizations can remain stable and resolve spontaneously.7,17 There are currently no clear recommendations regarding the screening or follow-up examinations for eye disorders in patients with IP, but early and periodic eye evaluations are warranted to evaluate retinal involvement, therefore allowing early intervention if abnormalities are detected.3,4 A study by Holmstrom and Thoren17 recommended prompt retinal evaluation immediately after birth, followed by monthly evaluations up to the age of three to four months, quarterly evaluations up to the age of one year, biannual evaluations up to the age of three years, and yearly evaluations throughout the childhood period. Oranges et al18 conducted a randomized controlled trial in which preterm newborn IP patients with retinopathy of prematurity (ROP) that administered oral propranolol (0.25 or 0.5 mg/kg/6 hours) to preterm newborn IP patients with retinopathy of prematurity caused by ischemic processes and neovascularization. As a result, propranolol showed significantly decreased ROP progression in newborn patients.20 In all two patients, the diagnosis of IP was based on the clinical manifestations and histopathological examination results. In both cases, retinal neovascularization was discovered on the peripheral side of the eye, and the patient was recommended for periodic follow-up with no specific intervention. At the three to four-month follow-up, the retinal neovascularization resolved spontaneously without any treatment. However, in the second case, visual impairments were discovered after the patient reached school age, and it could not be determined whether they were caused by IP or not.

Conclusion

The prognosis of IP is generally good but accompanying extracutaneous manifestations of the central nervous system and/or the eyes can affect quality of life, therefore early screening and regular follow up is necessary.
  12 in total

1.  The potential role of propranolol in incontinentia pigmenti.

Authors:  Teresa Oranges; May El Hachem; Cesare Filippeschi; Marco Romanelli; Luca Filippi
Journal:  Dermatol Ther       Date:  2021-01-10       Impact factor: 2.851

2.  Incontinentia pigmenti diagnostic criteria update.

Authors:  S Minić; D Trpinac; M Obradović
Journal:  Clin Genet       Date:  2013-07-21       Impact factor: 4.438

3.  Intrafamilial clinical variability in four families with incontinentia pigmenti.

Authors:  Luiza M Mariath; Fernanda D Santa Maria; Cláudia S Poziomczyk; Giovanni M Travi; Gabriela E Wachholz; Stephanie R De Souza; Ana E Kiszewski; Lavínia Schuler-Faccini
Journal:  Am J Med Genet A       Date:  2018-08-27       Impact factor: 2.802

4.  Unraveling incontinentia pigmenti: A comparison of phenotype and genotype variants.

Authors:  Rebecca Wang; Irene Lara-Corrales; Peter Kannu; Elena Pope
Journal:  J Am Acad Dermatol       Date:  2019-03-21       Impact factor: 11.527

Review 5.  Incontinentia pigmenti--ophthalmological observation of a series of cases and review of the literature.

Authors:  M O'Doherty; K Mc Creery; A J Green; I Tuwir; D Brosnahan
Journal:  Br J Ophthalmol       Date:  2010-09-09       Impact factor: 4.638

6.  Incontinentia pigmenti-associated ocular anomalies of paediatric incontinentia pigmenti patients in China.

Authors:  Jie Peng; Qi Zhang; Xinchun Long; Jia Zhang; Qiujing Huang; Yian Li; Kaiqin She; Peiquan Zhao
Journal:  Acta Ophthalmol       Date:  2018-08-03       Impact factor: 3.761

Review 7.  Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.

Authors:  Alexander L Berlin; Amy S Paller; Lawrence S Chan
Journal:  J Am Acad Dermatol       Date:  2002-08       Impact factor: 11.527

8.  Clinical study of 20 patients with incontinentia pigmenti.

Authors:  Claudia S Poziomczyk; Renan R Bonamigo; Fernanda D Santa Maria; Paulo R G Zen; Ana E Kiszewski
Journal:  Int J Dermatol       Date:  2015-11-06       Impact factor: 2.736

Review 9.  Multidisciplinary consensus recommendations from a European network for the diagnosis and practical management of patients with incontinentia pigmenti.

Authors:  C Bodemer; A Diociaiuti; S Hadj-Rabia; M P Robert; I Desguerre; M-C Manière; M de la Dure-Molla; P De Liso; M Federici; A Galeotti; F Fusco; S Fraitag; C Demily; C Taieb; M Valeria Ursini; M El Hachem; J Steffann
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07       Impact factor: 6.166

10.  Early management of sight threatening retinopathy in incontinentia pigmenti.

Authors:  Sarah Michel; Clothilde Reynaud; Alejandra Daruich; Smail Hadj-Rabia; Dominique Bremond-Gignac; Christine Bodemer; Matthieu P Robert
Journal:  Orphanet J Rare Dis       Date:  2020-08-27       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.